Remuneration and Nomination Committee - Corporate
Close
Find your Coloplast country website

Remuneration and Nomination Committee

The Remuneration and Nomination Committee consists of three members elected among the Board of Directors.The Remuneration and Nomination Committe members are:

Lars Rasmussen

Lars Rasmussen

Chairman of the Remuneration and Nomination Committee About Lars Rasmussen
Close

Lars Rasmussen

Download high resolution picture

Chairman

Born: 1959

Nationality: Danish

No. of shares in Coloplast207,392 B shares
(no change since 2020/21 Full-Year Financial Results)

Joined the board in 2018

Chairman of the Remuneration and Nomination Committee
Member of the Audit Committee

Other board and management positions:
- H. Lundbeck A/S: Chairman of the Board, chairman of the remuneration and nomination committee and member of the audit committee
- Chairman of the Danish Committee on Corporate Governance
- Chairman of the Life Science Council established by the Danish Government

Lars Rasmussen acted as Coloplast’s President & CEO from 2008 – 2018 and was a member of Coloplast’s executive management from 2001 - 2018. Lars Rasmussen has extensive executive management and board experience from international listed companies in the med-tech and pharma industry. Lars Rasmussen possesses in-dept knowledge within commercialisation of innovation, B2B and B2C sales models and efficiency improvements.

Lars Rasmussen holds a Bachelor of Science degree in Engineering from Aalborg University and an Executive MBA from SIMI.

Lars Rasmussen is not considered independent.

Close
Niels Peter Louis-Hansen

Niels Peter Louis-Hansen

Member of the Remuneration and Nomination Committee About Niels Peter Louis-Hansen
Close

Niels Peter Louis-Hansen

Download high resolution picture

Deputy Chairman

Born: 1947

Nationality: Danish

Joined the board in 1968

Member of the Remuneration and Nomination Committee

Other board and management positions:
- Aage og Johanne Louis-Hansens Fond: Chairman of the Board
- Aage og Johanne Louis-Hansen ApS: CEO
- N.P. Louis-Hansen ApS: CEO
- NPLH Anpartsinvest ApS: CEO

Through decades of board work, Niels Peter Louis-Hansen has gained in-dept knowledge of the industries in which Coloplast operates, its dynamics and key players as well as deep insight into strategy development. Furthermore, Niels Peter Louis-Hansen is a key contributor to preserving the Coloplast-culture.

Niels Peter Louis-Hansen holds a degree as Civiløkonom.

Niels Peter Louis-Hansen is not considered independent.

Close
Jette Nygaard-Andersen

Jette Nygaard-Andersen

Member of the Remuneration and Nomination Committee About Jette Nygaard-Andersen
Close

Jette Nygaard-Andersen

Download high resolution picture

Board Member

Born: 1968

Nationality: Danish

Joined the board in 2015

Member of the Remuneration and Nomination Committee

Other board and management positions:
- BetMGM, LLC: Board member
- Entain plc: CEO and Executive Director

Jette Nygaard-Andersen has held numerous international management positions. Currently, Jette Nygaard-Andersen is acting as CEO and Executive Director in Entain plc. Jette Nygaard-Andersen has considerable executive management and board experience within global med-tech, media & entertainment, and digital growth businesses. Jette Nygaard-Andersen has extensive experience within business and marketing strategies, digital transformation, optimization of customer experience and customer engagement, working with digital growth start-ups globally and M&A activities, including post integration.

Jette Nygaard-Andersen holds a MSc in Business, Finance & Economics from the University of Copenhagen and Executive Development Programs from INSEAD and Executive Leadership Programmes from Columbia University.

Jette Nygaard-Andersen is considered independent.

Close
Annette Brüls

Annette Brüls

Member of the Remuneration and Nomination Committee About Annette Brüls
Close

Annette Brüls

Download high resolution picture

Board Member

Born: 1971

Nationality: Belgian

Joined the board in 2021

Member of the Remuneration and Nomination Committee

Other board and management positions:
- Medela AG: CEO

Annette Brüls has considerable executive management experience within global medical device businesses. She has since 2018 been CEO of Medela AG, one of the world’s leading providers of breastfeeding products and medical vacuum technology. Prior to that, Annette Brüls spent 11 years with Medtronic holding several senior leadership positions in both Europe and the US. Annette Brüls has in-depth knowledge and understanding of product development and commercialization within the med-tech industry and in particular in chronic disease management, including digital services and value-based healthcare models.

Annette Brüls has an engineering degree in medical and electronic engineering from the University of Liège in Belgium.

Annette Brüls is considered independent.

Close
View desktop version